Investor's Business Daily on MSN
Dianthus Therapeutics has appreciated 12-fold over two years. What's going on?
Dianthus Therapeutics stock shot higher Monday after the company said it would advance its experimental CIDP treatment.
Morning Overview on MSN
Single DMT dose eased depression-like symptoms in mice, study finds
A single injection of N,N-dimethyltryptamine, the psychedelic compound found in ayahuasca, reversed depression-like symptoms in chronically stressed mice, according to a peer-reviewed study published ...
New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...
The 12-16-week open-label study evaluated Ruxoprubart as monotherapy in treatment-naïve PNH patients. Key findings include: CLEVELAND, March 09, 2026 (GLOBE NEWSWIRE) -- NovelMed Therapeutics Inc., a ...
Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...
Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...
Moore Norman Technology Center received a grant from The Boeing Company to fund an Advanced Visualization Immersive Development Lab for the school’s aviation programs. The Lab will be supported by ...
When your garden entrance has better curb appeal than most people’s entire front yards combined. Photo credit: Elizabethan ...
The FDA granted sibeprenlimab accelerated approval for nephropathy after data showed it cut IgA nephropathy proteinuria by about 50% via APRIL inhibition. The treatment landscape for immunoglobulin A ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果